Le, Thi Yen, et al. “FIRST-LINE TREATMENT OUTCOMES OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: SINGLE-CENTER REAL-WORLD DATA FROM VIETNAM, FROM 2020 TO 2026”. Journal of Military Pharmaco-Medicine, vol. 51, no. 8, Aug. 2026, pp. 152-61, doi:10.56535/jmpm.v51i8.2085.